Lysine-specific demethylase 1 (LSD1, also known as KDM1A) has been found to be highly expressed in neurocytoma, colon cancer, breast cancer and other tumor types [31], and high expression is associated with poor tumor prognosis. Here, KDM1A is linked to neoplasm.